Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Streptococcus pneumoniae Pneumolysin/ply Protein, N-His

Catalog #:   YXX23601 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q7ZAK5
Protein length: Met1-Asp471
Overview

Catalog No.

YXX23601

Expression system

E. coli

Species

Streptococcus pneumoniae (strain ATCC BAA-255 / R6)

Protein length

Met1-Asp471

Predicted molecular weight

55.06 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q7ZAK5

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Pneumolysin, PLY, Thiol-activated cytolysin, ply, spr1739

Data Image
References

Pneumococcal surface proteins as targets for next-generation vaccines: Addressing the challenges of serotype variation., PMID:40347702

Immunochemical Characteristics and Functional Activity of Monoclonal Antibodies Obtained to the Recombinant Form of Pneumolysin., PMID:39945949

Structural analysis of extracellular ATP-independent chaperones of streptococcal species and protein substrate interactions., PMID:39878509

Weakened Airway Epithelial Junctions and Enhanced Neutrophil Elastase Release Contribute to Age-Dependent Bacteremia Risk Following Pneumococcal Pneumonia., PMID:39778043

Pneumococcal pneumonia is driven by increased bacterial turnover due to bacteriocin-mediated intra-strain competition., PMID:39638898

Endothelial ENaC-α Restrains Oxidative Stress in Lung Capillaries in Murine Pneumococcal Pneumonia-associated Acute Lung Injury., PMID:39405473

Forsythoside B, the active component of Frosythiae fructuse water extract, alleviates Streptococcus pneumoniae virulence by targeting pneumolysin., PMID:39366754

Pneumolysin contributes to dysfunction of nasal epithelial barrier for promotion of pneumococcal dissemination into brain tissue., PMID:39345124

Pneumolysin-responsive liposomal platform for selective treatment of Streptococcus pneumoniae., PMID:39285123

A 3'UTR-derived small RNA represses pneumolysin synthesis and facilitates pneumococcal brain invasion., PMID:39271946

Molecular characterization of a novel putative pathogen, Streptococcus nakanoensis sp. nov., isolated from sputum culture., PMID:39269180

Cytokine secretion by in vitro cultures of lung epithelial cells, differentiated macrophages and differentiated dendritic cells incubated with pneumococci and pneumococcal extracellular vesicles., PMID:39254798

Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolus., PMID:39231629

Bacterial pore-forming toxin pneumolysin drives pathogenicity through host extracellular vesicles released during infection., PMID:39211544

Preliminary Evaluation of the Safety and Immunogenicity of a Novel Protein-Based Pneumococcal Vaccine in Healthy Adults Aged 18-49: A Phase Ia Randomized, Double Blind, Placebo-Controlled Clinical Study., PMID:39203953

Mucins protect against Streptococcus pneumoniae virulence by suppressing pneumolysin expression., PMID:39172520

Blocking HXA3-mediated neutrophil elastase release during S. pneumoniae lung infection limits pulmonary epithelial barrier disruption and bacteremia., PMID:39120139

From cytokines to chemokines: Understanding inflammatory signaling in bacterial meningitis., PMID:39116800

Analysis of Immunobiological Properties of Recombinant Streptococcus pneumoniae Pneumolysin., PMID:39090461

Pneumococcal Neuraminidases Increase Platelet Killing by Pneumolysin., PMID:39029905

Analysis of Toxicity of Recombinant Pneumolysin from Streptococcus pneumoniae., PMID:38960960

Glucose and Oxygen Levels Modulate the Pore-Forming Effects of Cholesterol-Dependent Cytolysin Pneumolysin from Streptococcus pneumoniae., PMID:38922127

Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxins., PMID:38670939

Klebsiella pneumoniae peptide hijacks a Streptococcus pneumoniae permease to subvert pneumococcal growth and colonization., PMID:38589539

Pneumococcal sialidase promotes bacterial survival by fine-tuning of pneumolysin-mediated membrane disruption., PMID:38483905

Estimates of differential toxin expression governing heterogeneous intracellular lifespans of Streptococcus pneumoniae., PMID:38411297

Influence of the mRNA initial region on protein production: a case study using recombinant detoxified pneumolysin as a model., PMID:38260740

Recombinant Pneumolysin of Pneumococci Induces TLR4 Expression and Maturation of Dendritic Cells In Vitro., PMID:38191877

Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage., PMID:38096222

Pericytes are protective in experimental pneumococcal meningitis through regulating leukocyte infiltration and blood-brain barrier function., PMID:37978545

Impact of Endogenous Pneumococcal Hydrogen Peroxide on the Activity and Release of Pneumolysin., PMID:37888624

Isorhamnetin as a novel inhibitor of pneumolysin against Streptococcus pneumoniae infection in vivo/in vitro., PMID:37839759

Recent progress in pneumococcal protein vaccines., PMID:37818378

Pore-forming activity of S. pneumoniae pneumolysin disrupts the paracellular localization of the epithelial adherens junction protein E-cadherin., PMID:37607057

ΔA146Ply-HA stem protein immunization protects mice against influenza A virus infection and co-infection with Streptococcus pneumoniae., PMID:37531919

The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy., PMID:37446214

The unremarkable alveolar epithelial glycocalyx: a thorium dioxide-based electron microscopic comparison after heparinase or pneumolysin treatment., PMID:37386200

A novel immuno-molecular strategy for the detection of Streptococcus pneumoniae serotypes in human cerebrospinal and middle ear fluids., PMID:37348647

Macrolides Decrease the Proinflammatory Activity of Macrolide-Resistant Streptococcus pneumoniae., PMID:37191519

Preparation a Recombinant Form of Pneumolysin Protein from Streptococcus pneumoniae., PMID:37160796

Pneumolysin as a target for new therapies against pneumococcal infections: A systematic review., PMID:36947540

Naturally-occurring serotype 3 Streptococcus pneumoniae strains that lack functional pneumolysin and autolysin have attenuated virulence but induce localized protective immune responses., PMID:36897919

Bacteria hijack a meningeal neuroimmune axis to facilitate brain invasion., PMID:36859544

Immunoinformatics-aided design of a new multi-epitope vaccine adjuvanted with domain 4 of pneumolysin against Streptococcus pneumoniae strains., PMID:36829109

Peptide linker increased the stability of pneumococcal fusion protein vaccine candidate., PMID:36777254

Wogonin attenuates the pathogenicity of Streptococcus pneumoniae by double-target inhibition of Pneumolysin and Sortase A., PMID:36747468

Dendritic spine loss deep in the neocortex and dendrite distortion with diffusion disturbances occur early in experimental pneumococcal meningitis., PMID:36704002

Meningitis-associated pneumococcal serotype 8, ST 53, strain is hypervirulent in a rat model and has non-haemolytic pneumolysin which can be attenuated by liposomes., PMID:36683678

Pneumolysin promotes host cell necroptosis and bacterial competence during pneumococcal meningitis as shown by whole-animal dual RNA-seq., PMID:36543127

A multiomics analysis of direct interkingdom dynamics between influenza A virus and Streptococcus pneumoniae uncovers host-independent changes to bacterial virulence fitness., PMID:36542660

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Streptococcus pneumoniae Pneumolysin/ply Protein, N-His [YXX23601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only